Market closed·Syncing…
SMEMarket closed · Close · 19 Nov

Remus Pharmaceuticals Limited REMUSshare price and chart

Remus Pharmaceuticals closed at ₹795.00 on 19 November 2026, down 0.92% on the day. The 52-week range is ₹580.00 to ₹1,039.00.

₹795.00The price one share last traded at, in rupees.▼ 0.92% · ₹7.38
52-wk low ₹58047% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹1,039

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on REMUS

Real prices, every charge counted. Pick one or write your own.
What Remus Pharmaceuticals Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Remus Pharmaceuticals, established in 2015, brands, markets and distributes complex specialty and off-patent pharmaceutical formulations in international markets, in oncology, cardiology, dermatology and diabetes, using an asset-light model with contract manufacturers.

1
1Sector

Pharmaceuticals & Biotechnology

2
2What it sells

Specialty and off-patent formulations

3
3Who buys it

International markets

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
39Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
76.9%Near average
today 76.9%20d avg 81.3%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 10.9%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.+3.0%1 monthHow much the share price has changed over the period.▼ 13.2%3 monthsHow much the share price has changed over the period.▼ 9.6%1 yearHow much the share price has changed over the period.▼ 1.4%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.62.5%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹937 Cr19 NovDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.19%last 12 months

Dividend historyCash the company has paid per share, year by year.

₹190 / year
Paid 4 of 4 yrs
on ₹1 lakh at today's price · 0.19% yield · ₹1.5/share
What each year paid, on ₹1 lakh
63
126
126
189
23
24
25
26*
* 2026 so far - more may still be declared this year

2026 has paid ₹1.50 per share, about ₹189 on ₹1 lakh at today's price. Earlier years are restated to today's share count, so a bonus or split never reads as a dividend cut. Dividends are at the company's discretion and can be cut or skipped.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
+6.7%a year, over 3 years
1 yr
+8.9%
3 yr
+6.7%

Held for 3 years this compounded at +6.7% a year. The last twelve months were up +8.9%. Price only, before dividends.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
70.95%promoter holding, as of 2026-09-30+2.6 pts since 2023
Promoter share since listing
2023-0570.95% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
71.0%
23.5%
Promoter71.0%Foreign (FII)5.1%Domestic (DII)0.4%Public & others23.5%
Who is buying, who is leavingJul 25 to Sep 26
Promoter71.0%+0.1 pts
Foreign (FII)5.1%+0.1 pts
Domestic (DII)0.4%-0.4 pts

Each line is that holder's share of all shares over the last 4 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Insider tradesPurchases and sales of the company's own shares by promoters, directors and senior staff.

Last 18 months
Buy
Alkaben Dipakkumar Shah
Promoter Group · 12-Jan-2026 15:15
2,600 sh
₹18.4 L
Buy
ARPIT DEEPAKKUMAR SHAH
Promoters · 29-Dec-2025 14:37
1,200 sh
₹8.8 L
Buy
Renosen Pharmaceuticals Private Limited
Promoter Group · 23-Dec-2025 15:28
500 sh
₹3.8 L
Buy
DHRUVALBEN V SHAH
Promoter Group · 15-Dec-2025 18:35
500 sh
₹3.6 L
Buy
Vinodkumar Gandalal Shah
Promoter Group · 12-Dec-2025 18:31
500 sh
₹3.6 L
Buy
Renosen Pharmaceuticals Private Limited
Promoter Group · 01-Oct-2025 18:27
200 sh
₹1.5 L
Buy
ROMA VINODBHAI SHAH
Promoters · 23-Sep-2025 17:57
3,000 sh
₹24.0 L
Buy
DHRUVALBEN V SHAH
Promoter Group · 13-Aug-2025 10:49
200 sh
₹1.7 L

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Analysts/Institutional Investor Meet/Con. Call Updates06-Nov-2026

Remus Pharmaceuticals Limited has informed the Exchange about Transcript

Analysts/Institutional Investor Meet/Con. Call Updates04-Nov-2026

Remus Pharmaceuticals Limited has informed the Exchange about Audio Recording

Investor Presentation04-Nov-2026

Remus Pharmaceuticals Limited has informed the Exchange about Investor Presentation

Press Release03-Nov-2026

Remus Pharmaceuticals Limited has informed the Exchange regarding a media release dated November 03, 2026

Record Date03-Nov-2026

Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 07-Nov-2026.

Dividend03-Nov-2026

Remus Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on November 03, 2026, declared Interim Dividend of Rs. 1.00 per equity share.

Outcome of Board Meeting03-Nov-2026

Remus Pharmaceuticals Limited has submitted to the Exchange Outcome of Board Meeting held on November 03, 2026

Analysts/Institutional Investor Meet/Con. Call Updates28-Oct-2026

Remus Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Certificate under SEBI (Depositories and Participants) Regulations, 201812-Oct-2026

Remus Pharmaceuticals Limited has informed the Exchange regarding Disclosure under Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

Certificate under SEBI (Depositories and Participants) Regulations, 201812-Oct-2026

Remus Pharmaceuticals Limited has informed the Exchange regarding Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

Shareholders meeting07-Oct-2026

Remus Pharmaceuticals Limited has submitted the Exchange a copy Scrutinizer report and voting results for Postal Ballot

Shareholders meeting30-Sep-2026

Remus Pharmaceuticals Limited has informed the Exchange regarding Scrutinizer Report and Voting results of 11th Annual General Meeting

Shareholders meeting29-Sep-2026

Remus Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026

Trading Window25-Sep-2026

Remus Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Copy of Newspaper Publication08-Sep-2026

Remus Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

Backtest idea · REMUSMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on REMUS
Backtest idea · REMUSLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on REMUS
Backtest idea · REMUSSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on REMUS
Your own ideaWrite a rule for REMUS in plain English“Buy REMUS when …”
Start writing
Buy the dip on REMUSBuy when RSI(14) drops below 30
52-week high breakout on REMUSBuy when closes at a 52-week high
Golden cross on REMUSBuy when 50-day EMA crosses above 200-day
Stochastic oversold on REMUSBuy when stochastic %K drops below 20
Pullback in an uptrend on REMUSBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹937 cr
Larger than 35% of 141 peers
sector middle ₹2,738 cr
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.2%
Higher than 58% of 141 peers
sector middle 0.1%

Peers are the listed companies in the exchange's own industry group: Pharmaceuticals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Backtest idea · REMUSStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on REMUS
Backtest idea · REMUSPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on REMUS
Backtest idea · REMUSBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on REMUS
Backtest idea · REMUS52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on REMUS
Backtest idea · REMUSGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on REMUS
MACD momentum on REMUSBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on REMUSBuy when closes below the lower Bollinger band
Supertrend rider on REMUSBuy when supertrend turns up
Buy the dip on REMUSBuy when RSI(14) drops below 30
52-week high breakout on REMUSBuy when closes at a 52-week high

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-8.0
+3.6
-6.1
+9.1
+1.6
+11.9
-7.6
+24.9
+0.4
-6.6
-5.7
·
+13.2%
11m
2025
-4.4
-9.9
+4.1
-9.8
+3.4
-5.7
-6.6
-3.1
-19.3
+0.1
-4.2
+1.8
-43.8%
2024
-14.0
-11.9
+18.9
+6.8
+0.8
+10.2
+4.2
+26.6
-3.0
-0.1
+3.6
-7.9
+30.5%
2023
·
·
·
·
·
+86.2
+14.4
+2.3
+17.9
+12.9
-1.9
+35.6
+286.4%
7m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-08-07BLUE LOTUS CAPITAL MULTI BAGGER FUND II · bulkSELL63,900₹830.19₹5.30 Cr
2023-07-26CHHATTISGARH INVESTMENTS LIMITED · bulkSELL8,000₹3,599.03₹2.88 Cr
2023-06-15JINENDRA G · bulkBUY7,500₹2,387.92₹1.79 Cr
2023-06-01INDIA EMERGING GIANTS FUND LIMITED · bulkBUY15,700₹2,079.23₹3.26 Cr
2023-06-01YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . · bulkSELL10,600₹2,079.90₹2.20 Cr
2023-05-29NEGEN CAPITAL SERVICES PRIVATE LIMITED · bulkBUY34,000₹1,793.90₹6.10 Cr
2023-05-29MONEYWISE FINANCIAL SERVICES PRIVATE LTD · bulkSELL10,700₹1,712.85₹1.83 Cr
2023-05-29JAIN SANJAY POPATLAL · bulkBUY10,000₹1,711.25₹1.71 Cr

Read enough? Test REMUS. “Buy REMUS when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free